Dr. Menzies has a long history of involvement in TB care and research, beginning with his years in Lesotho in Africa. Since his return to Montreal he has developed a TB research program of clinical and epidemiologic studies linked with a large multi-disciplinary clinical service at the Montreal Chest Institute. This service collaborates closely with the Public Health Unit of Montreal and Immigration Canada for screening of newly arrived foreign-born and others at high risk for tuberculosis. He initiated MIRTH - a multidisciplinary group of researchers with expertise in molecular epidemiology, geographic information systems analyses, public health, economic analyses and microbial as well as human genetics. Dr. Menzies has also been involved as a consultant to National TB Programs in the Dominican Republic, Guyana and Ecuador. He has several grants on TB, and has published over 100 papers based on the results of his research.
Dr. Marcel Behr is an associate professor of Medicine and a William Dawson Scholar at McGill University. He completed his MD (1990) at Queen’s University before going to McGill for his residency where he trained in Internal Medicine, Infectious Diseases and Medical Microbiology, while concurrently completing an MSc in Epidemiology and Biostatistics. He subsequently undertook post-doctoral fellowship training in molecular epidemiology and microbial genomics at Stanford University, with Dr. Peter Small, before returning to McGill to start his own research group in 1999. Dr. Behr held a Canadian Institutes of Health Research New Investigator Award and a Chercheur-Boursier Senior award from the Fonds de la Recherche en Santé du Québec. Dr. Behr's research is on mycobacterial diseases, focusing on the genomic basis of bacterial pathogenicity, with a long-standing interest in the BCG vaccine family.
Dr. Schwartzman did his MD training at McGill (1989), where he then completed residency training in internal medicine and respiratory diseases (1994). After obtaining his MPH at Harvard in 1995, he joined the Respiratory Epidemiology and Clinical Research Unit as a research fellow. He is currently an Associate Professor in the Department of Medicine, with associate membership in the Department of Epidemiology and Biostatistics. As a clinician-researcher, his research interests draw on the interplay between respiratory epidemiology, clinical care, and public health. His research has focused on: 1) the epidemiology of tuberculosis, with recent emphasis on molecular and geographic applications in Montreal; and 2) questions of health service delivery in tuberculosis and other respiratory disease contexts.
Assistant Professor, Department of Epidemiology and Biostatistics, McGill University
Dr. Nandini Dendukuri is Director of the Technology Assessment Unit of the McGill University Health Centre. She is also an Assistant Professor in the Department of Epidemiology and Biostatistics at McGill University and received her PhD in Biostatistics from the same department. She is a holder of salary awards from the FRSQ. Dr. Dendukuri has a strong research background and is the holder of research grants from the Canadian Institutes of Health Research (CIHR), Le Fonds québécois de la recherche sur la nature et les technologies (FRQNT), and Natural Sciences and Engineering Research Council of Canada (NSERC). She is also a collaborator on numerous national and international research projects in technology assessment and epidemiology working with organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) Her research interests lie in the area of evaluating diagnostic tests in the absence of a gold standard, meta-analysis of diagnostic test properties and Bayesian estimation of small proportions.
Dr. Keertan Dheda is an Associate Professor of Respiratory Medicine, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town, and associate member at the IIDMM, UCT. He holds a South African National Research Foundation Chair in Lung Infection and Immunity, is supported by a South African MRC Career Development Award, and is a Fellow of the University of Cape Town. He completed his PhD in Mycobacterial Immunity at UCL where he holds a Faculty and Honorary Consultant position at the Centre for Infectious Diseases and International Health. This post is embedded within the UCL-UCT Global Health Programme Initiative. The group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, development and validation of rapid and field-friendly diagnostics for tuberculosis, and outcome and intervention studies of drug-resistant tuberculosis. This work is funded by the MRC, NRF, EU FP7, EDCTP, NIH and other agencies.
Dr. SP Kalantri is a professor of internal medicine at MGIMS, Sevagram. He did his MD from Nagpur University and his MPH (epidemiology) from the University of California, Berkeley. His major areas of research interest are infectious diseases, diagnostic research, randomized controlled trials, ethics in health research, clinical epidemiology and evidence-based medicine.
Dr. Rajnish Joshi is an associate professor of internal medicine at MGIMS, Sevagram. He did his MD from MGIMS, Sevagram, and his MPH (epidemiology) from the University of California, Berkeley. He is currently completing his PhD (epidemiology) from University of California, Berkeley. His major areas of research interest are infectious diseases epidemiology, clinical epidemiology and evidence-based medicine.
Professor DJ Christopher is the head of pulmonary medicine at CMC, Vellore, one of India's top ranked medical schools. He has extensive experience in respiratory research and has done considerable work in the area of tuberculosis and chronic respiratory diseases.